Cardiovascular Advances in Research and Opportunities Legacy Act

Hozzl · 2024-04-17T23:45:03Z

Explore the details of House Bill 1193 Cardiovascular Advances in Research and Opportunities Legacy Act currently in Congress. Get insights into its purpose, current status, sponsors, and potential impact on Health. Stay informed on legislative developments.

4/17/2024, 11:45 PM

Summary of Bill HR 1193

Bill 117 HR 1193, also known as the Cardiovascular Advances in Research and Opportunities Legacy Act, aims to support and advance research in the field of cardiovascular health. The bill seeks to improve the prevention, diagnosis, and treatment of cardiovascular diseases, which are a leading cause of death in the United States.

The legislation includes provisions to increase funding for research on cardiovascular diseases, as well as to promote collaboration among researchers, healthcare providers, and other stakeholders in the field. It also calls for the development of new technologies and treatments to improve outcomes for patients with cardiovascular conditions.

Additionally, the bill includes measures to improve access to care for individuals with cardiovascular diseases, particularly in underserved communities. This includes efforts to increase awareness of risk factors for heart disease and stroke, as well as to expand access to preventive services and treatments. Overall, Bill 117 HR 1193 aims to address the significant public health burden of cardiovascular diseases in the United States by supporting research, innovation, and access to care in the field of cardiovascular health.

Current Status of Bill HR 1193

Bill HR 1193 is currently in the status of Bill Introduced since February 22, 2021. Bill HR 1193 was introduced during Congress 117 and was introduced to the House on February 22, 2021. Bill HR 1193's most recent activity was Became Public Law No: 117-244. as of December 20, 2022